With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, General procedure: [CuBr(CNR)3] (1-4). Any one of the isocyanides CNR (R=Xyl, 2-Cl-6-MeC6H3, 2-Naphtyl, Cy) (3.1mmol) was added to a suspension of CuBr (143mg, 1.0mmol) in chloroform (5mL) and the reaction mixture was stirred at RT for 1h. The solvent was removed in vacuo and the product was recrystallized by slow concentration of a CH2Cl2/hexane solution at RT to give colorless (1, 2, and 4) or orange (3) crystalline solid.
As the paragraph descriping shows that 7787-70-4 is playing an increasingly important role.
Reference£º
Article; Melekhova, Anna A.; Novikov, Alexander S.; Luzyanin, Konstantin V.; Bokach, Nadezhda A.; Starova, Galina L.; Gurzhiy, Vladislav V.; Kukushkin, Vadim Yu.; Inorganica Chimica Acta; vol. 434; (2015); p. 31 – 36;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”